The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies

Richard Potter, Kari Tanderup, Christian Kirisits, Astrid de Leeuw, Kathrin Kirchheiner, Remi Nout, Li Tee Tan, Christine Haie-Meder, Umesh Mahantshetty, Barbara Segedin, Peter Hoskin, Kjersti Bruheim, Bhavana Rai, Fleur Huang, Erik Van Limbergen, Max Schmid, Nicole Nesvacil, Alina Sturdza, Lars Fokdal, Nina Boje Kibsgaard JensenDietmar Georg, Marianne Assenholt, Yvette Seppenwoolde, Christel Nomden, Israel Fortin, Supriya Chopra, Uulke van der Heide, Tamara Rumpold, Jacob Christian Lindegaard, Ina Jurgenliemk-Schulz, Isabelle Dumas, Cyrus Chargari, Jamema Swamidas, Shyam Kishore Shrivastava, Gerry Lowe, Robert Hudej, Taran Paulsen Hellebust, Geetha Menon, Arun S. Oinam, Rachel Cooper, Peter Bownes, Elzbieta Van der Steen Banasik, Marit Sundset, Bradley Pieters, Ludy C. H. W. Lutgens, Elena Villafranca, Janaki Hadjiev, Francois Bachand, Beth Erickson, Geraldine Jacobson, EMBRACE Collaborative Grp

Research output: Contribution to journalReview articleAcademicpeer-review

Original languageEnglish
Pages (from-to)48-60
Number of pages13
JournalClinical and Translational Radiation Oncology
Volume9
DOIs
Publication statusPublished - 1 Feb 2018

Keywords

  • Cervix cancer
  • Brachytherapy
  • Adaptive radiotherapy
  • MRI guided radiotherapy
  • Local control
  • Morbidity
  • GUIDED ADAPTIVE BRACHYTHERAPY
  • ADVANCED CERVICAL-CANCER
  • DOSE-VOLUME PARAMETERS
  • RATE INTRACAVITARY BRACHYTHERAPY
  • MODULATED RADIATION-THERAPY
  • EXTERNAL-BEAM RADIOTHERAPY
  • STANDARDIZED UPTAKE VALUE
  • CARBON ION RADIOTHERAPY
  • LATE RECTAL TOXICITY
  • QUALITY-OF-LIFE

Cite this

Potter, R., Tanderup, K., Kirisits, C., de Leeuw, A., Kirchheiner, K., Nout, R., Tan, L. T., Haie-Meder, C., Mahantshetty, U., Segedin, B., Hoskin, P., Bruheim, K., Rai, B., Huang, F., Van Limbergen, E., Schmid, M., Nesvacil, N., Sturdza, A., Fokdal, L., ... EMBRACE Collaborative Grp (2018). The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies. Clinical and Translational Radiation Oncology, 9, 48-60. https://doi.org/10.1016/j.ctro.2018.01.001